Drug maker Ranbaxy Laboratories today said its President & Chief Financial Officer Omesh Sethi has resigned from the services of the company.
"Omesh Sethi, President & Chief Financial Officer has resigned from the services of the company, with effect from January 25, 2011," Ranbaxy Laboratories said in a filing to the Bombay Stock Exchange (BSE).
However, the company did not cite any reason for Sethi's exit, in the BSE filing.
Last year, Ranbaxy Laboratories's Managing Director and Chief Executive Officer Atul Sobti had stepped down from his positions effective August 19, and was replaced by Arun Sawhney, who was the then President of the company's global pharmaceutical business.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app